Indian Biotech Needs Faster Regulatory Processes- Report
According to a report by the Indian industry group CII, there is a need to expedite regulatory processes and eliminate unnecessary stages to speed...
Roche Pays $70M To Close The Gap On Cancer Cell Treatments
A private biotechnology startup called Arsenal Biosciences will receive $70 million from Roche in exchange for access to technology that the two businesses believe...
Japan Approves Daiichi Sankyo Blood Cancer Drug Ezharmia
Daiichi Sankyo, a Japanese company, has been concentrating on a series of antibody-drug conjugates, but it has achieved a world first in a field...
Alzheimers Medicine Change Helped Biden Win Medicare Costs
Despite the fact that the decision to severely restrict coverage of an expensive new Alzheimer's medicine, U.S. President Joe Biden celebrated success on September...
Testing Expert: Omicron Infection Protects Against Influenza
Everyone eligible for both shots will often receive them at the same time during the COVID and flu vaccination campaigns in the fall. Interestingly,...
Australia Encourages Further COVID-19 Vaccination Research
In order to ultimately enhance the outcomes and care for children and people with chronic conditions, especially as novel variants emerge, the Australian government...
Amyotrophic Lateral Sclerosis- FDA And NIH Learning More
The Critical Path for Rare Neurodegenerative Diseases (CP-RND), a new public-private partnership created to advance the development of treatments for amyotrophic lateral sclerosis (ALS)...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...